Kolexia
Mebazaa Alexandre
Anesthesie-réanimation
Hôpital Lariboisière
Paris, France
1.1 K Activités
2.2 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Défaillance cardiaque Maladie aigüe Choc Choc cardiogénique Maladie grave Atteinte rénale aigüe Sepsie Urgences COVID-19

Industries

Roche
29 collaboration(s)
Dernière en 2023
Abiomed
6 collaboration(s)
Dernière en 2022
Bayer
6 collaboration(s)
Dernière en 2023
Echosens
4 collaboration(s)
Dernière en 2023

Dernières activités

Biomarkers to predict the need for renal replacement therapy in severe acute kidney injury (bioMARkers in acute Kidney injury settings to predict interventions and outcomes: the MARKISIO study)
43rd International Symposium on Intensive Care & Emergency Medicine   19 mars 2024
Precision medicine in septic shock with enibarcimab: biomarker guided definition of target population
43rd International Symposium on Intensive Care & Emergency Medicine   19 mars 2024
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial.
Circulation. Heart failure   06 mars 2024
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial.
European journal of heart failure   05 mars 2024
2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Giornale italiano di cardiologia (2006)   28 février 2024
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors.
European journal of heart failure   23 février 2024
Outcomes of Patients With Cardiogenic Shock in Hub and Spoke Centers: The importance of Protocol Standardization at a Network Level.
Journal of cardiac failure   16 février 2024
Circulating Dipeptidyl Peptidase 3 Modulates Systemic and Renal Hemodynamics Through Cleavage of Angiotensin Peptides.
Hypertension (Dallas, Tex. : 1979)   09 février 2024
Effect of a transitional care model following hospitalization for heart failure: 3-year outcomes of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) randomized controlled trial.
European journal of heart failure   01 février 2024
AdrenOSS-2: A Double-Blind, Placebo-Controlled, Randomized, Multicenter, Proof of Concept and Dose-Finding Phase II Clinical Trial to Investigate the Safety, Tolerability and Efficacy of ADRECIZUMAB in Patients With Septic Shock and Elevated Adrenomedullin
Essai Clinique (Adrenomed AG)   31 janvier 2024